189 related articles for article (PubMed ID: 20452769)
1. Synthesis of 4-[(diethylamino)methyl]-phenol derivatives as novel cholinesterase inhibitors with selectivity towards butyrylcholinesterase.
Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Peng W; Song H
Bioorg Med Chem Lett; 2010 Jun; 20(11):3254-8. PubMed ID: 20452769
[TBL] [Abstract][Full Text] [Related]
2. Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase.
Decker M; Krauth F; Lehmann J
Bioorg Med Chem; 2006 Mar; 14(6):1966-77. PubMed ID: 16289855
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.
Piazzi L; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
Bioorg Med Chem; 2007 Jan; 15(1):575-85. PubMed ID: 17008100
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
Huang L; Luo Z; He F; Lu J; Li X
Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
[TBL] [Abstract][Full Text] [Related]
5. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.
Elsinghorst PW; Tanarro CM; Gütschow M
J Med Chem; 2006 Dec; 49(25):7540-4. PubMed ID: 17149883
[TBL] [Abstract][Full Text] [Related]
6. Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine.
Decker M
Eur J Med Chem; 2005 Mar; 40(3):305-13. PubMed ID: 15725500
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors.
Alptüzün V; Kapková P; Baumann K; Erciyas E; Holzgrabe U
J Pharm Pharmacol; 2003 Oct; 55(10):1397-404. PubMed ID: 14607022
[TBL] [Abstract][Full Text] [Related]
8. Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase.
Huang L; Luo Z; He F; Shi A; Qin F; Li X
Bioorg Med Chem Lett; 2010 Nov; 20(22):6649-52. PubMed ID: 20880702
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
[TBL] [Abstract][Full Text] [Related]
10. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling.
Delogu GL; Matos MJ; Fanti M; Era B; Medda R; Pieroni E; Fais A; Kumar A; Pintus F
Bioorg Med Chem Lett; 2016 May; 26(9):2308-13. PubMed ID: 26995529
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimer's disease.
Szymański P; Janik A; Zurek E; Mikiciuk-Olasik E
Pharmazie; 2011 Jun; 66(6):399-403. PubMed ID: 21699076
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.
Shen Q; Peng Q; Shao J; Liu X; Huang Z; Pu X; Ma L; Li YM; Chan AS; Gu L
Eur J Med Chem; 2005 Dec; 40(12):1307-15. PubMed ID: 16182411
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases.
Khalid A; Zaheer-ul-Haq ; Anjum S; Khan MR; Atta-ur-Rahman ; Choudhary MI
Bioorg Med Chem; 2004 May; 12(9):1995-2003. PubMed ID: 15080903
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
Huang L; Shi A; He F; Li X
Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
[TBL] [Abstract][Full Text] [Related]
17. Dialkyl phenyl phosphates as novel selective inhibitors of butyrylcholinesterase.
Law KS; Acey RA; Smith CR; Benton DA; Soroushian S; Eckenrod B; Stedman R; Kantardjieff KA; Nakayama K
Biochem Biophys Res Commun; 2007 Apr; 355(2):371-8. PubMed ID: 17307152
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
Zhan ZJ; Bian HL; Wang JW; Shan WG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
[TBL] [Abstract][Full Text] [Related]
20. Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.
Yan J; Sun L; Wu G; Yi P; Yang F; Zhou L; Zhang X; Li Z; Yang X; Luo H; Qiu M
Bioorg Med Chem; 2009 Oct; 17(19):6937-41. PubMed ID: 19726199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
